Back

Vascular dysfunction is associated with symptom severity and quality of life in wild-type transthyretin amyloid cardiomyopathy

30 August 2026 (15:15 - 16:00)
Organised by: Logo
Congress Presentation Part of: New insights into cardiac amyloidosis Infiltrative Myocardial Disease ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Mr Nobuhiro Ogasawara

Akita University Graduate School of Medicine, Akita (Japan)

7 More presentations in this session

Presentation thumbnail
Decoding peripartum cardiomyopathy through multi-omics: circulating and cellular signatures from the Italian multicenter registry
Doctor M. Carotenuto (Naples, IT)
Abstract
Presentation thumbnail
Premature hypertensive heart disease in working-age adults: global burden, inequalities and missed prevention opportunities (GBD 2021)
Doctor X. Dong (Beijing, CN)
Abstract
Presentation thumbnail
Diagnostic utility of three clinical scoring systems for transthyretin amyloid cardiomyopathy in elderly Asian patients with heart failure with preserved ejection fraction
Doctor M. Chen (Taipei, TW)
Abstract
Presentation thumbnail
Improvement of health status with acoramidis in patients with wild-type and variant transthyretin amyloid cardiomyopathy: KCCQ domains analysis from the ATTRibute-CM study
Doctor N. Sarswat (Chicago, US)
Abstract
Presentation thumbnail
Acoramidis improves health-related quality of life in wild-type and variant transthyretin amyloid cardiomyopathy: An EQ-5D-5L subgroup analysis from ATTRibute-CM
Doctor E. Joyce (Dublin, IE)
Abstract

Access the full session

Session thumbnail
New insights into cardiac amyloidosis

The Event

Event poster

ESC Congress 2026

30 August 2026 15:15 CET
You may be interested in
thumbnail
Congress Presentation
Burden of transthyretin amyloid cardiomyopathy in treatment-naive patients by heart failure severity: results from a large, non-interventional, real-world study
21 May 2023
thumbnail
Congress Presentation
Levels of ankle-brachial index and the risk of physical dysfunction in patients with heart failure
23 May 2023
thumbnail
Congress Presentation
Arterial-myocardial coupling in primary AL amyloidosis. A validation study of vascular involvement.
30 August 2024
thumbnail
Congress Presentation
Characterization of different phenotypes of microvascular dysfunction and their impact on angina severity in patients with chronic angina without obstructive coronary artery disease: The MiVa Study
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources